50 Mg - 25 Ml Liposomal Doxorubicin Hydrochloride Injection

Name: 50 Mg - 25 Ml Liposomal Doxorubicin Hydrochloride Injection
Brand: NEETCO BIOPHARMA
Price: 2500 INR
Availability: InStock

Price 2500 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

50 Mg - 25 Ml Liposomal Doxorubicin Hydrochloride Injection Specification

Dosage Form
Injection

Salt Composition
Liposomal Doxorubicin Hydrochloride

Indication
Used for the treatment of ovarian cancer, metastatic breast cancer, multiple myeloma, and Kaposis sarcoma

Feature
Encapsulated liposomal formulation for enhanced drug delivery and reduced cardiotoxicity

Ingredients
Doxorubicin Hydrochloride in liposomal carrier system

Application
Antineoplastic agent for intravenous administration

Ph Level
Approximately neutral

Physical Color/Texture
Opaque red liquid

Fermentation Smell
Odorless

Storage Instructions
Store between 2C 8C, protect from light, do not freeze

Shelf Life
24 months

About 50 Mg - 25 Ml Liposomal Doxorubicin Hydrochloride Injection

Discover the sizzling efficacy of 50 Mg - 25 Ml Liposomal Doxorubicin Hydrochloride Injection-your premium choice for astounding results in oncology care. This single-dose, USP-compliant cytotoxic injection comes ready-to-use, offering enhanced, lavish drug delivery via its encapsulated liposomal formulation to reduce cardiotoxicity while targeting cancer cells with soaring precision. Each opaque red vial is crafted under stringent standards for safe intravenous administration. Handle with care, as this potent antineoplastic agent must be handled by professionals. Pick yours today on sale, exclusively for prescription use, and experience treatment that meets the highest benchmarks. Ideal for distributor, supplier, exporter, and trader networks across India.

Versatile Application in Oncology

50 Mg - 25 Ml Liposomal Doxorubicin Hydrochloride Injection is designed for targeted treatment of ovarian cancer, metastatic breast cancer, multiple myeloma, and Kaposi's sarcoma. Its advanced liposomal formulation allows for precise intravenous administration, ensuring maximal therapeutic effect on malignancies. Suitable for hospital oncology units, this agent is applied directly into the bloodstream. With its neutral pH and odorless composition, it offers a user-friendly approach for health professionals, optimizing cancer management across specialized medical facilities.

Premium Shipment and Packaging Solutions

FOB Port and meticulous packaging details ensure the injection arrives in premium condition, maintaining efficacy. Each vial is securely stored and shipped under refrigerated conditions to protect from temperature fluctuation and light exposure. Delivery is prompt for both domestic and export markets, guaranteeing timely arrival. Whether ordered in bulk or individually, every shipment upholds rigorous standards, and tracking information is provided for assurance. Packaging specifies expiry date and batch number for reliable inventory management and patient safety.

FAQ's of 50 Mg - 25 Ml Liposomal Doxorubicin Hydrochloride Injection:

Q: How is the 50 Mg - 25 Ml Liposomal Doxorubicin Hydrochloride Injection administered?

A: This injection is intended for intravenous (IV) use only and should be handled by trained healthcare professionals due to its cytotoxic nature.

Q: What are the primary medical indications for this product?

A: The injection is used in the treatment of ovarian cancer, metastatic breast cancer, multiple myeloma, and Kaposi's sarcoma.

Q: What are the recommended storage conditions for this injection?

A: It should be stored between 2C - 8C, protected from light, and must not be frozen to maintain its efficacy.

Q: Which safety precautions should be followed during handling and administration?

A: As a cytotoxic and hazardous agent, appropriate personal protective equipment should be used, and it should not be mixed with other drugs in the same infusion line.

Q: What are the potential adverse effects of this medication?

A: Possible adverse effects include myelosuppression, mucositis, hand-foot syndrome, and cardiac toxicity. Close monitoring by healthcare professionals is advised.